Morphine Exacerbates Experimental Colitis-Induced Depression of Nesting in Mice

Area of Science:

• Pharmacology and Toxicology
• Neuroscience and Behavioral Science
• Gastroenterology and Inflammatory Bowel Disease Research

Background:

• Opioids and NSAIDs are common analgesics but may worsen Crohn's disease severity in patients.
• Behavioral depression is an indicator of reduced quality of life in inflammatory bowel disease (IBD).
• Nesting behavior in mice is a preclinical model sensitive to pain and analgesic effects.

Purpose of the Study:

• To investigate the effects of morphine (opioid) and ketoprofen (NSAID) on nesting behavior depression in a mouse model of colitis.
• To determine if these analgesics exacerbate or alleviate behavioral changes associated with experimental colitis.

Main Methods:

• Experimental colitis was induced in mice using 2, 4, 6-trinitrobenzene sulfonic acid (TNBS).
• Nesting behavior and locomotor activity were assessed following TNBS administration and daily treatment with morphine or ketoprofen.
• Dose-response effects of morphine (1-10 mg/kg) and ketoprofen (3.2-10 mg/kg) were evaluated.

Main Results:

• TNBS-induced colitis significantly depressed nesting behavior, with recovery by Day 7.
• Morphine (3.2 mg/kg) exacerbated TNBS-induced nesting depression and attenuated locomotor activity recovery.
• Ketoprofen did not prevent nesting depression in TNBS-treated mice.

Conclusions:

• Opioid analgesics, specifically morphine, can worsen behavioral depression associated with colonic inflammation.
• NSAIDs, like ketoprofen, did not show adverse effects on nesting behavior in this colitis model.
• Findings underscore the need to evaluate analgesic efficacy and safety in the context of inflammatory conditions.